Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Pharmaceuticals Regulatory News (HEMO)

Share Price Information for Hemogenyx Pharmaceuticals (HEMO)

Share Price is delayed by 15 minutes
Get Live Data
724.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 22.00 (3.034%)
Market Cap: £49.23m
HEMO Live PriceLast checked at - London Stock Exchange

Intraday Hemogenyx Pharmaceuticals Share Chart

Statement re possible acquisition

30 Dec 2015 07:00

RNS Number : 3726K
Silver Falcon PLC
30 December 2015
 

30 December 2015

SILVER FALCON PLC

("Silver Falcon" or the "Company")

 

Proposed acquisition of Lime Holdings Limited ("Lime")

 

Silver Falcon plc (LSE:SILF), the listed special purpose acquisition company, refers to its announcement of 23 December 2015 and is pleased to advise that it has entered into a non-binding Memorandum of Understanding with the board and principal shareholder in Lime Holdings Limited ("Lime") regarding a possible acquisition of 100% of the share capital of Lime by way of a share for share exchange ("Transaction").

Lime is an Australian unlisted public company which operates in the financial technology sector. It has developed an innovative platform for the insurance industry which facilitates the automated delivery of insurance to end users.

Lime has recently relocated its headquarters to the UK and is developing commercial partnerships in the UK and on an international basis.

Whilst a general understanding on the terms of the Transaction has been reached, these terms are subject to due diligence, a fundraising, and re-listing of the enlarged group on the London Stock Exchange. Accordingly there is no certainty that it will be completed.

If the Transaction is completed, it will constitute a reverse takeover under the Listing Rules. As the Company is unable to provide full disclosure under Rule 5.6.15 of the Listing Rules, the Company has requested a continuation of the current suspension of trading in its shares.

Further announcements will be made in due course as the Transaction progresses.

 

For further information please contact:

Silver Falcon: Tim Le Druillenec (Company Secretary), 07874 762821

Media enquiries: Jennifer Renwick, jennifer.renwick@camarco.co.uk, 0203 757 4994

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQTLBPTMBTTBAA
Date   Source Headline
5th May 202112:58 pmRNSConversion of Convertible Loan Notes
30th Apr 20212:27 pmRNSFinal Results
30th Apr 20217:00 amRNSTotal Voting Rights
26th Apr 202111:06 amRNSSecond Price Monitoring Extn
26th Apr 202111:00 amRNSPrice Monitoring Extension
26th Apr 20219:05 amRNSSecond Price Monitoring Extn
26th Apr 20219:00 amRNSPrice Monitoring Extension
26th Apr 20217:00 amRNSConversion of Convertible Loan Notes
16th Apr 202110:52 amRNSConversion of Convertible Loan Notes
14th Apr 20219:05 amRNSSecond Price Monitoring Extn
14th Apr 20219:00 amRNSPrice Monitoring Extension
14th Apr 20217:00 amRNSCDX Option Update
6th Apr 20214:41 pmRNSSecond Price Monitoring Extn
6th Apr 20214:36 pmRNSPrice Monitoring Extension
1st Apr 20217:00 amRNSCDX Antibody Update
31st Mar 20217:00 amRNSTotal Voting Rights
29th Mar 20214:40 pmRNSSecond Price Monitoring Extn
29th Mar 20214:35 pmRNSPrice Monitoring Extension
29th Mar 20212:05 pmRNSSecond Price Monitoring Extn
29th Mar 20212:00 pmRNSPrice Monitoring Extension
29th Mar 202111:05 amRNSSecond Price Monitoring Extn
29th Mar 202111:00 amRNSPrice Monitoring Extension
29th Mar 20217:00 amRNSAllotment of Shares
26th Mar 20217:00 amRNSConversion of Convertible Loan Notes
11th Mar 20214:41 pmRNSSecond Price Monitoring Extn
11th Mar 20214:36 pmRNSPrice Monitoring Extension
9th Mar 20214:41 pmRNSSecond Price Monitoring Extn
9th Mar 20214:36 pmRNSPrice Monitoring Extension
9th Mar 20212:06 pmRNSSecond Price Monitoring Extn
9th Mar 20212:00 pmRNSPrice Monitoring Extension
9th Mar 202111:00 amRNSPrice Monitoring Extension
9th Mar 20217:00 amRNSDirector/PDMR Shareholding
8th Mar 20217:00 amRNSH.C. Wainwright Investment Conference
3rd Mar 20217:00 amRNSHEMO-CAR-T Update
26th Feb 202110:05 amRNSTotal Voting Rights
25th Feb 20214:56 pmRNSConversion of Convertible Loan Notes
15th Feb 20214:41 pmRNSSecond Price Monitoring Extn
15th Feb 20214:36 pmRNSPrice Monitoring Extension
10th Feb 20217:00 amRNSAllotment of Shares
3rd Feb 20217:01 amRNSDraw Down Under Financing Facility Agreement
29th Jan 20212:24 pmRNSPublication of Prospectus
13th Jan 20217:00 amRNSUpdate on CDX Antibody Development
6th Jan 20213:53 pmRNSResult of General Meeting
5th Jan 20217:00 amRNSCAR-T Master Translational Agreement with Penn
8th Dec 20207:00 amRNSChange to Date of General Meeting
2nd Dec 20204:41 pmRNSSecond Price Monitoring Extn
2nd Dec 20204:36 pmRNSPrice Monitoring Extension
2nd Dec 202011:06 amRNSSecond Price Monitoring Extn
2nd Dec 202011:01 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSPosting of Circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.